Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Vice President, Finance, Corporate Controller and Principal
Accounting Officer
On April 27, 2021, Laura J. Wahlberg informed us of her intent to resign from C4
Therapeutics, Inc. (the "Company"), effective as of May 28, 2021. As of that
date, Ms. Wahlberg will cease to serve in the role of Vice President, Finance,
Corporate Controller and Principal Accounting Officer, and has agreed to provide
transitional services after her departure under the terms of a consulting
agreement.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses